Clinical Characteristics and Molecular Analysis of 21 Chinese Children with Congenital Agammaglobulinemia
Authors:
Open Access
- 13 August 2010
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 72 (5) , 454-459
Abstract
Congenital agammaglobulinemia is a humoral primary immunodeficiency and affected patients have extremely low levels of peripheral B cells and profound deficiency of all immunoglobulin isotypes. Mutations of the Bruton’s tyrosine kinase (BTK) gene are responsible for most of the congenital agammaglobulinemia. In this study, the phenotypes of congenital agammaglobulinemia were investigated in 21 male children from 21 unrelated Chinese families. Sixteen different mutations of BTK gene were identified in 18 patients, and three patients did not have BTK gene mutations. Nine mutations had been reported previously including one gross deletion (c.722_2041del), one missense mutation (c.1764G > T), three non‐sense mutations (c.194C > A, c.895C > T and c.1821G > A) and four invariant splice‐site mutations (c.971 + 2T > C, c.1481 + 2T > A, c.1482‐2A > G, c.1699‐2A > G). Seven novel mutations were identified (c.373_441del, c. 504delG, c.537delC, c.851delA, c.1637G > A, c.1879T > C and c. 1482_1882 del). Ten of the eighteen mutations of BTK gene were located in the TK domain, four in the PH domain, three in the SH3 domain and one spanned the TH, SH3, SH2 and TK domain. Candidate genes of autosomal‐recessive agammaglobulinemia, including IGHM, CD79a, CD79b and IGLL1, were screened in three patients without mutations in the BTK gene. A compound heterozygosity mutation in the IGHM gene (c.1956G > A, c.175_176insC) was identified in one patient. The results of our study further support that molecular genetic testing represents an important tool for early confirmed diagnosis of congenital agammaglobulinemia and may allow accurate carrier detection and prenatal diagnosis.Keywords
This publication has 21 references indexed in Scilit:
- Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked AgammaglobulinemiaJournal of Clinical Immunology, 2009
- Mutations of the Igβ gene cause agammaglobulinemia in manJournal of Experimental Medicine, 2007
- X-linked immunodeficienciesCurrent Allergy and Asthma Reports, 2004
- Clinical and molecular analysis of patients with defects in μ heavy chain geneJournal of Clinical Investigation, 2002
- Novel Igα (CD79a) gene mutation in a Turkish patient with B cell‐deficient agammaglobulinemiaAmerican Journal of Medical Genetics, 2002
- Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and AgammaglobulinemiaJournal of Experimental Medicine, 1998
- DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemiaHuman Molecular Genetics, 1995
- Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.Proceedings of the National Academy of Sciences, 1994
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993
- The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinasesNature, 1993